Healthcare
The British Medical Association (BMA) has called for the Office of Fair Trading (OFT) to extend its private healthcare market review to include insurers’ fee schedules.
Cancer charities have slammed the National Institute for Health and Clinical Excellence's (Nice) decision to reject a drug that prolongs the life of prostate cancer suffers for being too expensive.
Workplace stress has reached a four-year high with British workers being the most stressed compared to colleagues in some of the world’s biggest economies, a new report has found.
Other Healthcare articles
The coming year promises to be a tough one for the private healthcare sector, according to a new report from analyst Laing and Buisson.
Healix has voiced support for the use of open referrals within the private medical insurance (PMI) market but warned that insurers need to be more transparent about the process.
The Association of Medical Insurance Intermediaries (Amii) has announced 500 people have now passed the Chartered Insurance Institute (CII)/AMII IF7 private medical insurance (PMI) exam.
The PIP breast implant furore could prompt the creation of an insurance scheme for cosmetic surgery patients to prevent similar remedial problems in the future.
Bupa has launched a free iPhone and Android app to enable its international private medical insurance (IPMI) customers to access their policy information from anywhere in the world.
Bupa has reached an agreement with BMI Healthcare to re-introduce patient treatment at all but three of the hospital network’s facilities.
The Office of Fair Trading (OFT) should consider healthcare trusts as the most transparent form of corporate private medical insurance (PMI), specialists have said.
Bupa has hit back at claims by doctors that its open referrals process is ‘flawed on several levels’ and limits patient choice.
Deloitte has warned that 2012 will be another tough year for the healthcare sector after the number of businesses going into administration grew sharply last year.
Axa PPP has removed all cost and time limits for licensed cancer drug treatment for patients on its standard individual and SME plans.
Previous Next 
Most read articles
Most commented articles
Viewpoints
At the start of one of busiest times of year it is easy to think about all the obvious things...
In Focus
Transferring clients’ assets between organisations can be a major headache – often time...
Latest jobs
£25k - £30k + Excellent Bonus: Drew Chapman Search and Selection: Excellent opportunity for a part qualified IFA Sales Support Administrator looking for a position whereby they can assume further responsibility London
Coffee Lounge
Not only is there a huge selection of games but why not try your hand at our Daily Sudoku
The 50 best apps for advisers (part two)
Advisers face extra FSCS bill for £13m CfD failure
RBS pays out £500k after mis-selling annuity to dying man
HMRC extends higher-rate tax avoidance crackdown
FSA cautions on platform shareholdings